EVIDENCE-BACKED

Jungamals

The vitamins and minerals picky-eater diets miss -- in a kid-friendly chewable.

Kids' Health

PharmanexCell
Jungamals -- photo 1 of 3Jungamals -- photo 2 of 3Jungamals -- photo 3 of 3

$36.00

$45.00 save $9.00 -- applied automatically through this link

When you buy through our links, we earn a small commission -- and that is what funds all the free education here. It never costs you more. Products are not intended to diagnose, treat, cure, or prevent any disease.

What it is

A chewable children's multivitamin bringing together vitamins A, C, D, E, B6, and B12 with the minerals zinc and iodine, formulated to help cover everyday nutrient gaps common in a child's diet. It is the kids' entry point into the LifePak family, built for children too young for a standard adult multivitamin. Exact per-serving amounts are held as until verified against the current label.

Why the evidence supports it

A children's multivitamin earns its place the same way an adult one does -- as coverage for real, well-documented dietary shortfalls rather than a hero ingredient -- and vitamin D, zinc, and iodine are among the nutrients most often short in picky-eater diets. The broad evidence favors correcting a spread of small gaps over mega-dosing any single nutrient, which is how a sensible chewable is built. Framed that way it supports the cell's Build function -- the vitamins and minerals a growing child's cells use to build and maintain their own structures -- with the firm caveat that pediatric dosing must be exact and any new supplement is worth a word with your child's pediatrician.

What it supports

  • Supports a growing child's everyday vitamin and mineral needs
  • Provides zinc and iodine, minerals often short in children's diets
  • Supports normal immune-nutrient status with vitamins A, C, and D
  • Offers a chewable, kid-friendly way to help close everyday dietary gaps

Which function it supports

CellBuild
mineral balanceimmune-cell signaling

Ties to the cell's Build function -- supplying the vitamins and minerals a growing child's cells use to build and maintain their own structures.

Learn the why behind this pillar

How it relates to your cells and mind

Every product here ties back to a specific job your body does. This one touches the functions below -- follow either link to see the mechanism in full, then dig into the studies.

What it is made of -- and the mechanisms behind it

Each ingredient acts on several of the body's functions. Taken together, this product touches these cell and mind functions -- follow any to see the mechanism in full.

The ingredients

Mechanisms drawn from our ingredient knowledge base (8 profiled ingredients). Structure and function only -- not a treatment claim.

What’s actually in it

Label revision US PIP dated January 2026

Transcribed from the manufacturer’s official Product Information Page, exactly as printed. Ingredient names that link open our research page for that ingredient, with the studies behind it.

Supplement Facts panel for Pharmanex Kids Jungamals
Amount per age-based: 2-3 yrs 1 tablet; 4-8 yrs 2 tablets; 9-12 yrs 3 tabletsAmount% DV
Calories0 Cal
Total Carbohydrate1 g1%*
Total Sugars<1 g
Vitamin A100% as beta carotene1000 mcg RAE333%
Vitamin Cas sodium ascorbate20 mg133%
Vitamin D3as cholecalciferol6.7 mcg45%
Vitamin Eas d-alpha tocopheryl acetate10 mg167%
Vitamin K2as menaquinone-75 mcg17%
Thiaminas thiamin mononitrate0.3 mg60%
Riboflavin0.3 mg60%
Niacinas niacinamide4 mg NE67%
Vitamin B6as pyridoxine HCl0.4 mg80%
Folateas methyltetrahydrofolic acid111 mcg DFE74%
Vitamin B12as methylcobalamin0.7 mcg78%
Biotin7 mcg88%
Pantothenic Acidas d-calcium pantothenate1.5 mg75%
Cholineas choline bitartrate13 mg7%
Calciumas calcium lithothamnion, calcium citrate42 mg6%
Magnesiumas magnesium hydroxide, magnesium citrate18 mg23%
Zincas zinc citrate2.5 mg83%
Seleniumas L-selenomethionine20 mcg100%
Manganeseas manganese bisglycinate0.7 mg58%
Copperas copper gluconate0.25 mg83%
Iodineas potassium iodide45 mcg50%
Ironas ferrous fumarate2 mg29%
Molybdenumas molybdenum glycinate11 mcg65%
Chromiumas chromium nicotinate glycinate8 mcg73%
Sodium0 mg0%
Lycopene1 mg
Lutein0.33 mg
Servings per container:
90
Other ingredients:
Sucrose, xylitol, natural flavors (grape, lemon), magnesium stearate, malic acid, carmine (color).

AMOUNTS ABOVE ARE PER 1 TABLET (the 2-3 year serving). The panel carries three age columns -- 1, 2 and 3 tablets, with servings per container 90 / 45 / 30 respectively. Never quote a dose from this product without saying which age tier it belongs to.

Source: official Product Information Page . Amounts are the manufacturer’s, not ours. Structure and function only -- nothing here is medical advice, and nothing here may be used to diagnose, treat, cure, or prevent any disease.

The science on the ingredients

These studies are research on the ingredients and mechanisms in this product, not on the finished product itself, and they are shown for education. Nothing here is medical advice, and nothing here may be used to diagnose, treat, cure, or prevent any disease. Talk to your own provider about what is right for you.

Powered by CellWell.life
  • Genetic Testing in Inherited Retinal Disease: Current Strategies and Future DirectionsEmergingExpert review2026

    This review traces inherited retinal disease genetic testing from older linkage methods to modern gene sequencing, noting that variants of uncertain significance remain a barrier to diagnosis, and that a genetic diagnosis is often needed for access to gene-directed treatments.

    Sujin Kang; Byron L Lam; Winston Lee; Audina M Berrocal; Ninel Z Gregori; Carlos E Mendoza-Santiesteban; Jesse D Sengillo

  • Long-read Sequencing in Inherited Retinal Dystrophies: A Systematic ReviewEmergingExpert review2026

    Across 26 studies reviewing long-read DNA sequencing in inherited retinal disease, this newer method identified 88 variants across 81 patients that shorter-read sequencing had missed, though formal accuracy data remain limited.

    Mariam Ibrahim; Alain Chebly; Said El Shamieh

  • From Genetic Diagnosis to Therapeutic Implementation in Retinal Diseases: Translational Advances and Persistent BottlenecksEmergingExpert review2026

    A review of genetic retinal disease notes that polygenic risk scores for complex conditions like glaucoma and macular degeneration are limited by ancestry bias and incomplete predictive performance, even as diagnostic yield for single-gene inherited retinal dystrophies reaches 70-80%.

    Feliciana Menna; Corrado Pinelli; Laura De Luca; Alessandro Meduri; Antonio Baldascino; Stefano Lupo; Enzo Maria Vingolo

  • Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory PainEmergingExpert review2026

    This review summarizes preclinical and clinical research suggesting carotenoids reduce pain hypersensitivity, inflammation, and oxidative stress in neuropathic and inflammatory pain models, without presenting new data itself.

    Fatemeh Abbaszadeh; Masoumeh Jorjani; Roshanak Amirian; Sajad Fakhri; Haroon Khan

  • Synaptic control of retinal ganglion cell survival and axon regenerationEmergingExpert review2026

    A 2026 review argues that after optic nerve injury like in glaucoma, changes in synaptic connections between retinal interneurons and ganglion cells, not just the neuron's own growth capacity, help determine if the cell survives and its axon regrows.

    Yuxuan Qiu; Qi Zhang; Jiahui Tang; Yunjie Cheng; Yuxin Wang; Zijie Wang; Xuehan Liu; Bing Zhang; Liyan Liu; Shilong Yu; Yangjiani Li; Zhe Liu; Fang Chai; Yehong Zhuo; Yiqing Li

  • Revisiting retinal and macular degeneration in the genomics eraEmergingExpert review2026

    A review of retinal and macular degeneration genetics notes that extensive genetic diversity and poor genotype-to-symptom correlation have slowed therapy development, though new sequencing and modeling tools are beginning to reveal causal genes and gene networks.

    Anand Swaroop; Botond Roska

  • Reflection Spectroscopy Skin Carotenoids Correlate with Serum Carotenoids in School-Aged ChildrenEmergingCross-sectional survey2026

    In school-aged children, noninvasive skin carotenoid readings correlated significantly with blood serum carotenoids, supporting reflection spectroscopy as a valid, needle-free way to assess carotenoid status in pediatric populations.

    Liu R, Rosok LM, Black M, Erdman JW, Khan NA. -- The Journal of nutrition

  • Phytochemicals and REDOX Modulation: Molecular Mechanisms, Clinical Relevance, and Therapeutic Perspectives.2026

    A review found that phytochemicals such as polyphenols, flavonoids, and carotenoids act as redox modulators affecting cellular signaling and inflammation, mechanisms studied for relevance to chronic diseases including cardiovascular and neurodegenerative conditions.

    Singh DD; Yadav DK; Shin D -- Antioxidants (Basel, Switzerland)

  • Stargardt Disease Presenting as Retinitis Pigmentosa: A Case of Monoallelic ABCA4-Associated RetinopathyEmergingCase report2026

    In a 48-year-old woman with a single heterozygous ABCA4 gene variant previously classified as benign, retinal exam findings resembled a different inherited disorder, retinitis pigmentosa, illustrating how one-copy ABCA4 variants can produce unexpectedly variable retinal phenotypes.

    Kevin Santiago-Narváez; Ricardo A Murati Calderon; Natalio Izquierdo

  • Redox regulation of PDE6 and cGMP signaling in diabetic retinal neurodegeneration.2026

    Redox imbalance is proposed to disrupt PDE6 enzyme activity and cGMP signaling in photoreceptors through proteostasis mechanisms, a pathway implicated in diabetic retinal neurodegeneration.

    Perez-Martinez CJ; Lewis-Luján LM; Cota-Arrayales CA; Guerrero-Magaña DE; Vargas-Durazo JT; Trushin MV; Osadchuk MA; Iloki-Lewis AP; Galvez-Ruiz JC; Iloki-Assanga SB -- Biochemistry and biophysics reports

  • From enrichment to interpretation: PS4-driven reclassification in Taiwanese inherited retinal degenerationEmergingCase-control study2026

    In a Taiwanese cohort of 802 inherited retinal degeneration patients compared against a national biobank's genetic data, applying a case-control statistical criterion (PS4) upgraded two variants from likely pathogenic to pathogenic and reclassified six from uncertain significance to likely pathogenic.

    Yu-Shu Huang; Chien-Yu Lin; Yu-An Chen; Chieh-Yu Lee; Chang-Hao Yang; Jacob Shujui Hsu; Ta-Ching Chen; Pei-Lung Chen

  • Vitamin A and its relationship with insulin secretion and diabetes mellitus: a review.2026

    Vitamin A and its retinoid derivatives influence pancreatic beta-cell development, insulin secretion, and protection against oxidative damage, with retinoids also shown to reduce autoimmune processes in type 1 diabetes.

    Dahmer DSV; Spada ECL; Allebrandt Neto EW; Silva WBD; Latorraca MQ; Lemes SAF -- Anais da Academia Brasileira de Ciencias

  • Prevalence of Xerophthalmia and Associated Factors Among Pregnant Women in Tigray Region, EthiopiaEmerging2026

    In 1355 pregnant Ethiopian women in Tigray, 25 percent had xerophthalmia, a sign of vitamin A deficiency, and not taking iron supplements was one of the significant risk factors.

    Ebud Ayele Dagnazgi; Shewit Engdashet Berhe; Guesh Gebreayezgi; Goitom Girmay Gebremariam; Yohannes Kinfe Gebreyohannes; Tsega Gebremichael Gebremeskel; Embaba Tekelaye Welesemayat; Teklehaymanot Huluf Abraha; Gebregziabher Kidanemariam Asfaw

  • Antioxidant regulatory mechanisms of retinoic acid and its therapeutic potential in oxidative stress-related diseases.2026

    A review found that retinoic acid, a vitamin A metabolite, regulates antioxidant gene expression through nuclear receptors and the Nrf2-Keap1 pathway, with studied relevance to oxidative-stress-related conditions including neurodegeneration.

    Tang Y; Lv D; Hu W -- Biochemical pharmacology

  • Genome-wide association study reveals genetic architecture and evolution of human retinal pigmentationEmergingObservational study2026

    A genome-wide study using deep learning to measure eye pigmentation found 26 new genetic loci, with heritability of 21.4%, and a polygenic score for retinal pigmentation linked to higher myopia risk and lower skin cancer risk.

    Jian Yuan; Yue Zhang; Yinghao Yao; Shasha Li; Jiacheng Liang; Wei Dai; Jiaying Yang; Mengyao Liu; Qinyi Zhang; Yao Zhou; Jiahang Li; Hui Liu; Zhen Ji Chen; Stuart MacGregor; Jia Qu; Xikun Han; Jianzhong Su

  • Deconstructing White Dot Syndromes-Multimodal Imaging in Uveitis (MUV) Taskforce: Report 11.2026

    A perspective review used advanced retinal imaging techniques to critically re-examine whether 'white dot syndromes,' a historical grouping of non-infectious posterior uveitis conditions, remains a clinically valid diagnostic category.

    Invernizzi A; Agarwal A; Jampol LM; Sadda SR; Cimino L; Gangaputra S; Staurenghi G; Tugal-Tutkun I; El-Asrar AMA; Pavesio CE; Jabs DA; McCluskey P; Okada AA; Agrawal R; Accorinti M; DE Smet M; Sarraf D; Gupta V; Multimodal Imaging in Uveitis (MUV) Task Force -- American journal of ophthalmology

  • Systematic functional evaluation of CNGA1 missense variants associated with retinitis pigmentosaEmergingPrimary research (design unspecified)2026

    Functional testing of 86 CNGA1 gene variants linked to an inherited retinal disease found 72% impaired channel function, allowing 62% of variants first classified as uncertain to be reclassified as likely pathogenic or benign.

    Peggy Reuter; Jennifer Schroeder; Marc Sturm; Mathieu Quinodoz; Veronika Vaclavik; Miriam Bauwens; Marieke De Bruyne; Bart Leroy; Joseph van Aerschot; Katarina Stingl; Susanne Kohl

  • A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional CharacterizationEmergingPrimary research (design unspecified)2026

    In a four-generation family carrying an ARL3 gene variant, lab testing showed the mutant protein disrupted normal cell trafficking, yet affected relatives ranged from extensive retinal damage to no clinical signs at all regardless of age, showing incomplete penetrance.

    Stellacci E; Ziccardi L; Bruselles A; Dell'Aquila C; Mignini L; Niceta M; Chiriatti L; Carvetta M; Zara E; Leone A; Cecchetti S; Coppola S; Parisi V; Tartaglia M; Cordeddu V -- International journal of molecular sciences

  • Unravelling effects of resorcinol: Morphological alterations in the retina and thyroid follicles of zebrafish (Danio rerio) embryosEmerging2026

    In zebrafish embryos, exposure to resorcinol, a chemical used in industry and cosmetics, caused thyroid gland tissue to grow larger at lower doses, likely compensating for blocked hormone production, and thinned retinal tissue at the highest dose.

    Chabchoubi IB; Stoll M; Rinderknecht M; Reger L; Behnstedt L; Braunbeck T; Baumann L; Hentati O; Gölz L -- Aquatic toxicology (Amsterdam, Netherlands)

  • Retinal Tear as a Sign of an IgA Nephropathy Flare: A Case ReportEmergingCase report2026

    In a case report, retinal tear presented as a likely indication of an IgA nephropathy flare, showing that ocular manifestations warrant assessment in these patients.

    Ying Luu; Ray R Goshtaseb

  • Chronic exposure to aerosolized Arizona test dust reduces visual acuity in miceEmerging2026

    Mice exposed to aerosolised Arizona test dust three hours daily for up to four months showed reduced visual acuity from one month, fewer cone photoreceptors and retinal ganglion cells, and raised Nrf2 pathway gene expression.

    Milin J Patel; Maumita Datta; Valentina Baredes; Tiffany Fuentes-Gonzalez; Shiloh Bass; Diego Alba; Adam C Soloff; Abigail S Hackam

  • Bis(2-ethylhexyl)tetrabromophthalate disrupts thyroid hormone signaling and causes visual impairment in zebrafish larvaeEmerging2026

    Zebrafish larvae exposed to the brominated flame retardant TBPH had smaller eyes, thinner retinal layers and lower ganglion cell density, with docking suggesting competitive binding to transthyretin disrupting the thyroid axis.

    Li XT; Wang Z; Sun S; Xing WL; Liang MY; Wang L; Liu HL -- Aquatic toxicology (Amsterdam, Netherlands)

  • A brief history of the human liver peroxisomeEmerging2026

    This review of human liver peroxisomes drew on hundreds of patients, highlighting peroxisome mosaics in liver, changes within one patient over time, and contact site deficiencies causing retinal dystrophy with leukodystrophy.

    Dirk De Craemer; Christiane Van den Branden; Frank Roels

  • Long-distance object motion evokes direction selectivity in retinal neurons through nicotinic receptors in bipolar cellsEmerging2026

    In mouse retina, long-distance moving bars evoked stronger direction selectivity than local bars in starburst amacrine and ganglion cells, and the alpha7 antagonist MLA reduced that enhancement.

    Jeremy M Bohl; Andrew M Garrett; Tomomi Ichinose

Balanced by design -- we show supporting and contradicting findings. Search all studies

If you have had labs done

These are lab markers where this product's ingredients have measured evidence in our citation library. This is not a claim that the product will change your results -- the research attaches to the ingredient, and what a marker means depends on the whole picture. Each one links to its full entry, including what typically moves it and how to read it.

  • Zincsolid evidence

    via Zinc · 2,123 studies, 444 in people

    What people often notice when this marker sits outside the usual range

    Higher: Nausea and metallic taste at high oral doses.

    Lower: Frequent colds that last longer than everyone else's.

  • Zincsolid evidence

    via Zinc · 2,123 studies, 444 in people

    Studied alongside selenium in subclinical hypothyroidism.

    What people often notice when this marker sits outside the usual range

    Lower: For the full symptom picture in both directions, read the main zinc entry -- it is the same measurement, and repeating it here would only risk the two drifting apart.

  • via Zinc · 2,123 studies, 444 in people

    What people often notice when this marker sits outside the usual range

    Higher: ⚠️ THE ZINC:COPPER RATIO'S REAL CONTENT IS A SAFETY WARNING, AND IT IS A GOOD ONE.

    Lower: Low zinc: loss or dulling of taste and smell, slow wound healing, acne, white spots on nails, hair thinning, frequent colds, low testosterone, poor night vision.

  • via Vitamin D · 795 studies, 345 in people

    What people often notice when this marker sits outside the usual range

    Higher: ⚠️ Toxicity risk is hypercalcaemia and kidney stones.

    Lower: The general deficiency picture -- fatigue, aching bones and muscles, low mood worse in winter, frequent illness, hair loss, slow healing.

  • via Vitamin B12 · 546 studies, 181 in people

    What people often notice when this marker sits outside the usual range

    Higher: Tingling, numbness or burning in the feet and hands, usually symmetrical and worse at night.

    Lower: Normal MMA is the reassuring result and carries no symptoms.

  • Seleniumsolid evidence

    via Zinc · 262 studies, 72 in people

    What people often notice when this marker sits outside the usual range

    Higher: A garlic smell on the breath with no garlic eaten -- the classic early sign.

    Lower: Frequent infections and slow recovery from them -- selenium is required by the immune system's antioxidant defences.

Lab results are interpreted by a qualified clinician who knows your history. Nothing here diagnoses anything or replaces that conversation.

No product works in isolation

Every cell function above -- Sense, Exchange, Transform, Build, Maintain, Adapt -- needs the same broad base of optimal micronutrient levels running underneath it, all the time. Jungamals is not a stand-alone fix; it is one piece that plugs into that larger system. The foundation comes first, and this supports it.

Stacks well with

Pick your goal -- here is what Jungamals pairs with for each. Nothing works in isolation; these share the same systems.

Foundational, or targeted?

Not everything in the shop is meant to be taken forever. Some products here are foundational -- a daily nutrient base built for long-term, ongoing use. Others are targeted -- shorter-term support for a specific season, not a lifelong habit. If you are not sure which one this is, that is a fair question to ask us before you buy.

Learn more, on your terms

Do not take our word for it -- go read. Each topic below opens a pre-loaded search so you can explore the nutrient, the mechanism, or the device for yourself.

Search the full studies library

How to use it

Give the labeled daily chewable serving with a meal, following the current bottle's age and serving guidance. Always follow pediatric dosing exactly and check with your child's pediatrician before starting any new supplement.

Where to get it

Ready when you are. This link takes you to the official, verified source for this product.

Get Jungamals

Optimal nutrients are the definition of longevity

Long-term cell function depends on having what it needs, at the level it needs it, for as long as it needs it. That is the whole thesis behind everything we point you to here.

When you buy through our links, we earn a small commission -- and that is what funds all the free education here. It never costs you more. Products are not intended to diagnose, treat, cure, or prevent any disease.

Jungamals is a chewable children's multivitamin bringing together vitamins A, C, D, E, B6 and B12 with zinc and iodine. It is built for the everyday gaps a child's diet leaves, especially a picky one.

FAQ

What does Jungamals support?

It supports normal growth and development, normal immune function, and helps cover the everyday vitamin and mineral gaps common in children's diets.

How do I take it?

One chewable a day, per the label, with or after food. ⚠️ Keep it out of reach of children between doses, as with any supplement that tastes good.

What makes it different?

It is a chewable built for the nutrients picky-eater diets actually miss, rather than a sweetened token multivitamin.